RPE65-Associated Retinopathies in the Italian Population: A Longitudinal Natural History Study.
Adolescent
Adult
Child
Child, Preschool
DNA
/ genetics
DNA Mutational Analysis
Electroretinography
Female
Genetic Association Studies
Genotype
Humans
Incidence
Italy
/ epidemiology
Male
Middle Aged
Mutation
Phenotype
Retinal Dystrophies
/ diagnosis
Retrospective Studies
Tomography, Optical Coherence
Visual Acuity
Visual Fields
Young Adult
cis-trans-Isomerases
/ genetics
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
entrez:
7
2
2022
pubmed:
8
2
2022
medline:
25
2
2022
Statut:
ppublish
Résumé
To investigate the course of inherited retinal degenerations (IRD) due to mutations in the RPE65 gene. This longitudinal multicentric retrospective chart-review study was designed to collect best corrected visual acuity (BCVA), Goldman visual field, optical coherence tomography (OCT), and electroretinography (ERG) measurements. The data, including imaging, were collected using an electronic clinical research form and were reviewed at a single center to improve consistency. From an overall cohort of 60 Italian patients with RPE65-associated IRD, 43 patients (mean age, 27.8 ± 19.7 years) were included and showed a mean BCVA of 2.0 ± 1.0 logMAR. Time-to-event analysis revealed a median age of 33.8 years and 41.4 years to reach low vision and blindness based on BCVA, respectively. ERG (available for 34 patients) showed undetectable responses in most patients (26; 76.5%). OCT (available for 31 patients) revealed epiretinal membranes in five patients (16.1%). Central foveal thickness significantly decreased with age at a mean annual rate of -0.6%/y (P = 0.044). We identified 43 different variants in the RPE65 gene in the entire cohort. Nine variants were novel. Finally, to assess genotype-phenotype correlations, patients were stratified according to the number of RPE65 loss-of-function (LoF) alleles. Patients without LoF variants showed significantly (P < 0.05) better BCVA compared to patients with one or two LoF alleles. We described the natural course of RPE65-associated IRD in an Italian cohort showing for the first time a specific genotype-phenotype association. Our findings can contribute to a better management of RPE65-associated IRD patients.
Identifiants
pubmed: 35129589
pii: 2778418
doi: 10.1167/iovs.63.2.13
pmc: PMC8822366
doi:
Substances chimiques
DNA
9007-49-2
retinoid isomerohydrolase
EC 3.1.1.64
cis-trans-Isomerases
EC 5.2.-
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13Références
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4433-9
pubmed: 15557452
Int J Mol Sci. 2021 Jul 05;22(13):
pubmed: 34281261
Klin Monbl Augenheilkd. 2014 Apr;231(4):405-10
pubmed: 24771178
Hum Mutat. 2001 Aug;18(2):164
pubmed: 11462243
Am J Ophthalmol. 2009 May;147(5):847-58, 858.e1
pubmed: 19200530
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Eur J Ophthalmol. 2021 Jan;31(1):158-165
pubmed: 31617414
Invest Ophthalmol Vis Sci. 2010 May;51(5):2608-14
pubmed: 19959640
Invest Ophthalmol Vis Sci. 2009 May;50(5):2368-75
pubmed: 19117922
Mol Ther. 2018 Jan 3;26(1):256-268
pubmed: 29033008
Arch Ophthalmol. 2000 Apr;118(4):538-43
pubmed: 10766140
J Bone Joint Surg Am. 2020 Jul 1;102(13):1109-1115
pubmed: 32618908
Lancet. 2009 Nov 7;374(9701):1597-605
pubmed: 19854499
Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4293-9
pubmed: 11095629
Br J Ophthalmol. 2016 Nov;100(11):1499-1505
pubmed: 26906952
Mol Ther. 2021 Feb 3;29(2):442-463
pubmed: 33278565
Nat Genet. 1997 Oct;17(2):139-41
pubmed: 9326927
Hum Mutat. 2010 Oct;31(10):E1709-66
pubmed: 20683928
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):292-302
pubmed: 20811047
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4284-90
pubmed: 17724218
Hum Mol Genet. 2008 Jan 15;17(2):281-92
pubmed: 17933883
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3642-55
pubmed: 26047050
Confin Neurol. 1954;14(2-3):184-6
pubmed: 13190865
Curr Diabetes Rev. 2021;17(2):161-168
pubmed: 32619173
Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):47
pubmed: 32347917
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):13
pubmed: 33576794
Orphanet J Rare Dis. 2021 Jun 4;16(1):257
pubmed: 34088339
Am J Ophthalmol. 2019 Mar;199:58-70
pubmed: 30268864
Orphanet J Rare Dis. 2021 Apr 13;16(1):174
pubmed: 33952291
Genet Med. 2015 Apr;17(4):271-8
pubmed: 25356976
Eur J Hum Genet. 1998 Sep-Oct;6(5):527-31
pubmed: 9801879
Ophthalmol Retina. 2019 Jun;3(6):535
pubmed: 31174678
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
JAMA Ophthalmol. 2021 Sep 1;139(9):956-963
pubmed: 33662099
PLoS One. 2015 Jul 06;10(7):e0131679
pubmed: 26147992
Br J Ophthalmol. 2017 Sep;101(9):1147-1154
pubmed: 28689169
Br J Ophthalmol. 2020 Jul;104(7):932-937
pubmed: 31630094
Vision Res. 2003 Dec;43(28):3087-93
pubmed: 14611946
Exp Eye Res. 2021 Nov;212:108761
pubmed: 34492281
Doc Ophthalmol. 2020 Jun;140(3):289-297
pubmed: 31925606
Physiol Genomics. 2017 Apr 1;49(4):216-229
pubmed: 28130426
Br J Ophthalmol. 2001 Apr;85(4):424-7
pubmed: 11264131
Hum Genet. 2011 Mar;129(3):319-27
pubmed: 21153841
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5235-42
pubmed: 18599565
Ophthalmology. 2011 May;118(5):888-94
pubmed: 21211845
Am J Ophthalmol. 2004 Feb;137(2):375-7
pubmed: 14962443
Biomed Res Int. 2018 Aug 2;2018:3095961
pubmed: 30175123
Retina. 2020 Sep;40(9):1812-1828
pubmed: 32032261
Ophthalmic Epidemiol. 2012 Jun;19(3):159-65
pubmed: 22568429
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4065-71
pubmed: 19339744
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3052-9
pubmed: 16123401
J Cataract Refract Surg. 2004 Feb;30(2):287-90
pubmed: 15030802
Med Arh. 1999;53(3 Suppl 3):73-5
pubmed: 10870633
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3330-3339
pubmed: 30025081
Hum Mutat. 2004 Apr;23(4):306-17
pubmed: 15024725
Lancet. 2017 Aug 26;390(10097):849-860
pubmed: 28712537
Ophthalmology. 2004 Aug;111(8):1585-94
pubmed: 15288992
Ophthalmology. 2016 Sep;123(9):1887-97
pubmed: 27378015
Nat Genet. 1997 Oct;17(2):194-7
pubmed: 9326941
Prog Retin Eye Res. 2008 Jul;27(4):391-419
pubmed: 18632300
Sci Rep. 2017 Apr 10;7:46285
pubmed: 28393863
PLoS One. 2013 Sep 16;8(9):e73172
pubmed: 24066033
Mol Vis. 2010 Dec 03;16:2550-8
pubmed: 21151602
J Telemed Telecare. 2011;17(1):20-4
pubmed: 21097561
Eur J Ophthalmol. 2017 Nov 8;27(6):762-768
pubmed: 28525683
Eur J Hum Genet. 2016 Jul;24(7):1071-9
pubmed: 26626312
Am J Hum Genet. 1999 Apr;64(4):1225-8
pubmed: 10090910
J Telemed Telecare. 2013 Dec;19(8):437-42
pubmed: 24162839
Arch Ophthalmol. 2002 Jan;120(1):55-61
pubmed: 11786058
Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2735-42
pubmed: 10937591
Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):417-26
pubmed: 15565294
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034
Transl Vis Sci Technol. 2021 Aug 12;10(10):11
pubmed: 34554209
Mol Vis. 2000 Oct 30;6:192-8
pubmed: 11062306
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3088-93
pubmed: 9501220
Retina. 2017 Aug;37(8):1581-1590
pubmed: 27828912
Mol Ther. 2020 Jan 8;28(1):266-278
pubmed: 31604676
Prog Retin Eye Res. 2010 Sep;29(5):398-427
pubmed: 20399883